Inhibited Temperament: An Early Risk Factor for Schizophrenia

August 29, 2019
https://discover.vumc.org/2019/07/inhibited-temperament-an-early-risk-factor-for-schizophrenia/?utm_campaign=discover-newsletter-29-08-2019&utm_source=marketo&utm_medium=email
Schizophrenia is a heterogeneous disorder, with patients exhibiting diverse clinical manifestations. Identifying pre-morbid factors that account for variability in schizophrenia is of interest to improve the identification of predisposed individuals and to provide more personalized, effective treatment. New research suggests childhood inhibited temperament may be a pre-morbid difference to target in preventative interventions.

Taylor co-authors JAMA Psychiatry article on age-related mental disorders

August 29, 2019
As the percentage of U.S. adults older than 65 years continues to grow, so too does the need for preventing mental illness among older adults as well as improving clinical services and outcomes for older patients with psychiatric disorders. Psychiatry's obligation to treat this population, and an agenda for research and enhancement of clinical services, is outlined by Warren D. Taylor, M.D., M.H.Sc., James G. Blakemore Professor of Psychiatry and Director, Division of General Psychiatry, and Charles F.

Erin Connor

Erin
Connor
Post-Doctorate Fellow
Psychiatry

Graduate School: Tennessee State University

Additional Degrees: M.A. Clinical Mental Health Counseling from George Washington University; B.A.s in Psychology and Justice Studies from James Madison University

Internship: Jackson Health System in affiliation with the University of Miami Miller School of Medicine

Clinical Interests: Interventions that promote self-management of chronic medical conditions and/or psychological distress for adults, mind-body therapies, and culturally sensitive practice. 

Sarah Sperry

Sarah
Sperry
Post-Doctorate Fellow
Psychiatry

Graduate School: University of Illinois at Urbana-Champaign

Internship: Medical University of South Carolina

Clinical Interests: Bipolar spectrum disorders, alcohol use disorder, digital phenotyping, mHealth interventions, the use of ambulatory assessment methods to understand individual level risk factors, illness trajectories, and treatment response. 

 

 

Jessica Schwartzman

Jessica
Schwartzman
Post Doctorate Fellow
Psychiatry

Graduate School: Palo Alto University

Internship: Vanderbilt University Medical Center Autism and Lifespan Development Track

Clinical Interests: Evidence-based interventions for youth and adults with autism, neuropsychological assessment, family resilience, and clinical trials.

Jolene Jacquart

Jolene
Jacquart
Psychology Intern
Psychiatry

Graduate School: University of Texas, Austin

Internship: Vanderbilt University Medical Center General Adult Outpatient

Clinical Interests: Evidence-based interventions for treating anxiety and mood disorders, CBT, third-wave therapies, health behavior change, mind-body practices

Beshaun Davis

Beshaun
Davis
Psychology Intern
Psychiatry

Graduate School: Indiana University-Purdue University, Indianapolis

Internship: Vanderbilt University Medical Center Psychosis Track

Clinical Interests: Recovery-oriented care, metacognitive deficits, insight, evidenced-based interventions for psychosis.

Amanda Broderick

Amanda
Broderick
Post-Doctorate Fellow
Psychiatry

Graduate School: Pennsylvania State University

Internship:Vanderbilt University Medical Center Child and Adolescent Psychiatry

Clinical Interests: Evidence-based interventions for children and adolescents, trauma-informed treatment, parent-child relationships.

Sarah Meyer, D.O.

Sarah
Meyer
D.O.

Hometown: Kalamazoo, MI

Undergrad: Michigan State University

Medical: Michigan State University College of Osteopathic Medicine

 

Psychiatry interests: Geriatric Psychiatry, with a focus on medication interactions and medical complications, electroconvulsive therapy, bioethics, medical education, and community advocacy

RSS: